Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Tomažič J[au]:

Search results

Items: 1 to 50 of 53

1.

HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.

Kowalska JD, Bursa D, Gökengin D, Jilich D, Tomazic J, Vasylyev M, Bukovinowa P, Mulabdic V, Antonyak S, Horban A; ECEE Network Group.

HIV Med. 2018 Oct;19(9):629-633. doi: 10.1111/hiv.12641. Epub 2018 Jul 10.

PMID:
29989332
2.

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.

Lunar MM, Židovec Lepej S, Tomažič J, Vovko TD, Pečavar B, Turel G, Maver M, Poljak M.

PLoS One. 2018 Apr 26;13(4):e0196670. doi: 10.1371/journal.pone.0196670. eCollection 2018.

3.

Three Perspectives on Mental Health Told through StoryCorps' "Liza Long and 'Michael'".

Tomazic JC, Ogunmuyiwa JO, Ferber GA.

AMA J Ethics. 2018 Jan 1;20(1):19-24. doi: 10.1001/journalofethics.2018.20.1.peer3-1801.

4.

The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.

Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.

HIV Med. 2018 Feb;19(2):90-101. doi: 10.1111/hiv.12546. Epub 2017 Aug 31.

5.

A36 Prevalence of HIV-1 subtypes in Slovenia with an emphasis on molecular and phylogenetic investigation of subtype A.

Mlakar J, Lunar MM, Abecasis AB, Vandamme AM, Tomažič J, Vovko TD, Pečavar B, Volčanšek G, Poljak M.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.035. doi: 10.1093/ve/vew036.035. eCollection 2017 Mar. No abstract available.

6.

Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.

Borges ÁH, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Tomazic J, Gargalianos-Kakolyris P, Schmid P, Orkin C, Pedersen C, Leen C, Pradier C, Mulcahy F, Ridolfo AL, Staub T, Maltez F, Weber R, Flamholc L, Kyselyova G, Lundgren JD, Mocroft A; for EuroSIDA.

Clin Infect Dis. 2017 May 15;64(10):1413-1421. doi: 10.1093/cid/cix167. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

PMID:
28329090
7.
8.

Infection-related and -unrelated malignancies, HIV and the aging population.

Shepherd L, Borges Á, Ledergerber B, Domingo P, Castagna A, Rockstroh J, Knysz B, Tomazic J, Karpov I, Kirk O, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.

HIV Med. 2016 Sep;17(8):590-600. doi: 10.1111/hiv.12359. Epub 2016 Feb 18.

9.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

10.

HIV resistance testing and detected drug resistance in Europe.

Schultze A, Phillips AN, Paredes R, Battegay M, Rockstroh JK, Machala L, Tomazic J, Girard PM, Januskevica I, Gronborg-Laut K, Lundgren JD, Cozzi-Lepri A; EuroSIDA in EuroCOORD.

AIDS. 2015 Jul 17;29(11):1379-89. doi: 10.1097/QAD.0000000000000708.

PMID:
26091300
11.

Longitudinal trends of recent HIV-1 infections in Slovenia (1986-2012) determined using an incidence algorithm.

Lunar MM, Matković I, Tomažič J, Vovko TD, Pečavar B, Poljak M.

J Med Virol. 2015 Sep;87(9):1510-6. doi: 10.1002/jmv.24209. Epub 2015 May 12.

PMID:
25970253
12.

Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.

Merkac MI, Tomazic J, Strle F.

Infection. 2015 Dec;43(6):759-62. doi: 10.1007/s15010-015-0779-5. Epub 2015 Apr 29.

PMID:
25922085
13.

Bridging epidemiology with population genetics in a low incidence MSM-driven HIV-1 subtype B epidemic in Central Europe.

Lunar MM, Vandamme AM, Tomažič J, Karner P, Vovko TD, Pečavar B, Volčanšek G, Poljak M, Abecasis AB.

BMC Infect Dis. 2015 Feb 15;15:65. doi: 10.1186/s12879-015-0802-6.

14.

Relationship between markers of endothelial dysfunction and inflammation and subclinical atherosclerosis in HIV-infected male patients below 55 years of age.

Pirš M, Jug B, Eržen B, Šabović M, Karner P, Poljak M, Tomažič J.

Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(3):49-52.

15.

Cardiovascular risk assessment in HIV-infected male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations.

Pirš M, Jug B, Eržen B, Šabović M, Karner P, Poljak M, Tomažič J.

Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(3):43-7.

16.

Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIV-infected individuals in Slovenia: a 1986-2013 update.

Škamperle M, Seme K, Lunar MM, Maver PJ, Tomažič J, Vovko TD, Pečavar B, Matičič M, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(2):25-6.

17.

Early atherosclerosis in HIV-infected patients below the age of 55 years: Slovenian national study.

Pirs M, Eržen B, Sabović M, Karner P, Vidmar L, Poljak M, Jug B, Mikac M, Tomažič J.

Wien Klin Wochenschr. 2014 May;126(9-10):263-9. doi: 10.1007/s00508-014-0516-6. Epub 2014 Mar 21.

PMID:
24652011
18.

Syphilis and HIV co-infection: excellent response to multiple doses of benzathine penicillin.

Saje A, Tomažič J.

Acta Dermatovenerol Alp Pannonica Adriat. 2014 Mar;23(1):1-3.

19.

Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.

Swenson LC, Cobb B, Geretti AM, Harrigan PR, Poljak M, Seguin-Devaux C, Verhofstede C, Wirden M, Amendola A, Boni J, Bourlet T, Huder JB, Karasi JC, Zidovec Lepej S, Lunar MM, Mukabayire O, Schuurman R, Tomazic J, Van Laethem K, Vandekerckhove L, Wensing AM; International Viral Load Assay Collaboration.

J Clin Microbiol. 2014 Feb;52(2):517-23. doi: 10.1128/JCM.02461-13. Epub 2013 Dec 4.

20.

Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.

Borstnar S, Lindic J, Tomazic J, Kandus A, Pikelj A, Prah J, Skvarc M, Godnov U, Kovac D.

Transplant Proc. 2013 May;45(4):1614-7. doi: 10.1016/j.transproceed.2013.02.107.

PMID:
23726632
21.

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.

Lunar MM, Židovec Lepej S, Abecasis AB, Tomažič J, Vidmar L, Karner P, Vovko TD, Pečavar B, Maver PJ, Seme K, Poljak M.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):343-9. doi: 10.1089/AID.2012.0152. Epub 2012 Aug 29.

22.

Severe human granulocytic anaplasmosis transmitted by blood transfusion.

Jereb M, Pecaver B, Tomazic J, Muzlovic I, Avsic-Zupanc T, Premru-Srsen T, Levicnik-Stezinar S, Karner P, Strle F.

Emerg Infect Dis. 2012 Aug;18(8):1354-7. doi: 10.3201/eid1808.120180.

23.

Spotlight on measles 2010: a cluster of measles in a hospital setting in Slovenia, March 2010.

Grgic-Vitek M, Frelih T, Ucakar V, Prosenc K, Tomazic J, Petrovec M, Kraigher A.

Euro Surveill. 2010 May 20;15(20). pii: 19573.

24.

Low prevalence of hepatitis B and C infections among HIV-infected individuals in Slovenia: a nation-wide study, 1986-2008.

Seme K, Lunar MM, Tomazic J, Vidmar L, Karner P, Maticic M, Poljak M.

Acta Dermatovenerol Alp Pannonica Adriat. 2009 Dec;18(4):153-6.

25.

Review of calciphylaxis and treatment of a severe case after kidney transplantation with iloprost in combination with hyperbaric oxygen and cultured autologous fibrin-based skin substitutes.

Alikadic N, Kovac D, Krasna M, Lindic J, Sabovic M, Tomazic J, Jeras M, Smrke D.

Clin Transplant. 2009 Nov-Dec;23(6):968-74. doi: 10.1111/j.1399-0012.2009.01062.x. Epub 2009 Aug 27.

PMID:
19712088
26.

Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.

Lindic J, Rupnik AT, Tomazic J, Skoberne A, Gucek A, Ferluga D, Pintar T, Ales A, Kovac D, Kveder R, Pajek J, Savicki-Ponikvar B, Bren A.

Ther Apher Dial. 2009 Aug;13(4):282-7. doi: 10.1111/j.1744-9987.2009.00725.x.

PMID:
19695060
27.

HLA-B*5701 screening for hypersensitivity to abacavir.

Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team.

N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135.

28.

Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients.

Grego K, Arnol M, Bren AF, Kmetec A, Tomaziĉ J, Kandus A.

Transplant Proc. 2007 Dec;39(10):3093-7.

PMID:
18089329
30.

Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.

Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P, Prezelj J, Vidmar G, Vidmar L.

Wien Klin Wochenschr. 2007;119(21-22):639-46.

PMID:
18043884
31.

Osteomyelitis of parietal bone in melioidosis.

Miksić NG, Alikadić N, Lejko TZ, Andlovic A, Knific J, Tomazic J.

Emerg Infect Dis. 2007 Aug;13(8):1257-9. No abstract available.

32.

Clinical features and virologic characteristics of primary and early HIV-1 infection in Slovenian patients.

Pirs M, Poljak M, Seme K, Babic DZ, Tomazic J.

Coll Antropol. 2006 Dec;30 Suppl 2:47-52.

PMID:
17508474
33.

HIV-1 subtype B epidemic and transmission patterns in Slovenia.

Babic DZ, Seme K, Tomazic J, Vidmar L, Poljak M.

Coll Antropol. 2006 Dec;30 Suppl 2:25-31.

PMID:
17508470
34.

Multiple infections after commercial renal transplantation in India.

Tomazic J, Pirs M, Matos T, Ferluga D, Lindic J.

Nephrol Dial Transplant. 2007 Mar;22(3):972-3. Epub 2006 Nov 28. No abstract available.

PMID:
17132708
35.

Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005.

Babic DZ, Poljak M, Seme K, Tomazic J, Vidmar L.

J Med Virol. 2006 Aug;78(8):997-1002.

PMID:
16789023
36.

Genetic variability of gag and env regions of HIV type 1 strains circulating in Slovenia.

Mezei M, Balog K, Babic DZ, Tóth G, Cech G, Vajna B, Tauber T, Seme K, Tomazic J, Vidmar L, Poljak M, Minárovits J.

AIDS Res Hum Retroviruses. 2006 Jan;22(1):109-13.

PMID:
16438653
37.

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.

Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.

Virus Res. 2006 Jun;118(1-2):156-63. Epub 2006 Jan 18.

PMID:
16417938
38.

Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.

Tomazic J, Karner P, Vidmar L, Maticic M, Sharma PM, Janez A.

Acta Dermatovenerol Alp Pannonica Adriat. 2005 Sep;14(3):99-105.

39.

Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.

Tomazic J, Silic A, Karner P, Vidmar L, Maticic M, Poljak M, Ihan A, Janez A.

Wien Klin Wochenschr. 2004 Nov 30;116(21-22):755-9.

PMID:
15628647
40.

Low prevalence of hepatitis C virus infection among human immunodeficiency virus type 1-infected individuals from Slovenia and Croatia.

Seme K, Poljak M, Begovac J, Vince A, Tomazic J, Vidmar L, Kniewald T.

Acta Virol. 2002;46(2):91-4.

PMID:
12387500
41.

Influenza vaccination of human immunodeficiency virus 1-infected patients receiving antiretroviral therapy.

Banic S, Koren S, Tomazic J, Vidmar L, Ihan A, Poljak M, Avsic-Zupanc A.

Acta Virol. 2001 Feb;45(1):39-44.

PMID:
11394576
42.

Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease.

Maticic M, Poljak M, Kramar B, Tomazic J, Vidmar L, Zakotnik B, Skaleric U.

J Dent Res. 2000 Jul;79(7):1496-501.

PMID:
11005734
43.

Seroprevalence of HIV-1 subtypes A-E among HIV-1 infected individuals from Slovenia.

Poljak M, Seme K, Marin IJ, Tomazic J, Vidmar L, Maticic M, Kasper P.

Pflugers Arch. 2000;439(3 Suppl):R45-6.

PMID:
10653138
44.

Seroprevalence of HIV-1 subtypes A-E among HIV-1 infected individuals from Slovenia.

Poljak M, Seme K, Marin IJ, Tomažič J, Vidmar L, Matičič M, Kasper P.

Pflugers Arch. 2000 Jan;439(Suppl 1):r045-r046. doi: 10.1007/s004240000086.

PMID:
28176069
45.

Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals.

Poljak M, Tomazic J, Seme K, Maticic M, Vidmar L.

Acta Virol. 1998 Feb;42(1):23-6.

PMID:
9645239
46.

Immunological differentiation between tickborne encephalitis with and without concomitant neuroborreliosis.

Tomazic J, Ihan A, Strle F, Cimperman J, Stare J, Maticic M, Zakotnik B.

Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):920-3.

PMID:
9495674
47.
48.

Tick-borne encephalitis: possibly a fatal disease in its acute stage. PCR amplification of TBE RNA from postmortem brain tissue.

Tomazic J, Poljak M, Popovic P, Maticic M, Beovic B, Avsic-Zupanc T, Lotric S, Jereb M, Pikelj F, Gale N.

Infection. 1997 Jan-Feb;25(1):41-3.

PMID:
9039538
49.

Transmission of HIV-1 by human bite.

Vidmar L, Poljak M, Tomazic J, Seme K, Klavs I.

Lancet. 1996 Jun 22;347(9017):1762. No abstract available.

PMID:
8656918
50.

Ex vivo effect of azithromycin in human leukocyte bactericidal functions.

Tomazic J, Maticic M, Kotnik V, Simcic S, Wraber B, Zakotnik B.

Antimicrob Agents Chemother. 1995 Aug;39(8):1906. No abstract available.

Supplemental Content

Loading ...
Support Center